Advertisement

Topics

Japan Drug Delivery Devices Market Outlook to 2023 Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices [Report Updated: 01082017] Prices from USD $5995

09:50 EDT 2 Aug 2017 | BioPortfolio Report Blog

Japan Drug Delivery Devices Market Outlook to 2023 Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

GlobalData's new report, "Japan Drug Delivery Devices Market Outlook to 2023", provides key market data on the Japan Drug Delivery Devices market. The report provides value, in millions of US dollars and volume in units within market categories Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporatelevel profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders KOLs, physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Drug Delivery Devices market categories Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
Annualized market revenues USD million and volume units data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
2016 company shares and distribution shares data for each of the market categories.
Global corporatelevel profiles of key companies operating within the Japan Drug Delivery Devices market.
Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy

Develop business strategies by identifying the key market categories poised for strong growth in the future.
Develop marketentry and market expansion strategies.
Design competition strategies by identifying whostandswhere in the market.
Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
What are the key distribution channels and what's the most preferred mode of product distribution Identify, understand and capitalize.

Original Article: Japan Drug Delivery Devices Market Outlook to 2023 Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices [Report Updated: 01082017] Prices from USD $5995

NEXT ARTICLE

More From BioPortfolio on "Japan Drug Delivery Devices Market Outlook to 2023 Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices [Report Updated: 01082017] Prices from USD $5995"

Quick Search
Advertisement
 

Relevant Topics

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...